Mesenchymal Stem Cell Conditioned Medium as Good as Methyl Prednisolone in Decreasing Levels of Interleukin 10 and The Degree of Pulmonary Vasculitis in Lupus Mice

Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive an...

Full description

Saved in:
Bibliographic Details
Published inBangladesh journal of medical science (Ibn Sina Trust) Vol. 20; no. 2; pp. 426 - 430
Main Authors Prabowo, Nurhasan Agung, Adnan, Zainal Arifin, Nurudhin, Arief, Werdiningsih, Yulyani, Prasetyo, Kukuh
Format Journal Article
LanguageEnglish
Published Dhaka Ibn Sina Trust 01.02.2021
Subjects
Online AccessGet full text
ISSN2223-4721
2076-0299
DOI10.3329/bjms.v20i2.51560

Cover

Abstract Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive and anti-inflammatory properties. This study aims to compare the therapeutic effect of mesenchymal stem cell conditioned medium administration compared to methyl prednisolone on interleukin 10 levels and the degree of pulmonary vasculitis of lupus mice. Methods: The subjects were 24 female mice of Mus musculus Balb/C strain, which were categorized into 4 groups of 8 mice, i.e. the control group receiving 0.5 cc of 0.9% NaCl injection and placebo, the lupus group receiving 0.5 cc of pristane injection and placebo, and the treatment mesenchymal stem cell conditioned medium group receiving 0.5 cc pristane injection and mesenchymal stem cell conditioned medium 0,5 cc, and methylprednisolone group receiving 0,5 cc pristiane injection and methylprednisolone p.o 1,5 mg/kgbodyweight. After 24 days the mice were terminated and kidney and blood samples were taken. Statistical analysis was performed using ANOVA test followed by independent T-test. The p value was considered significant when the p < 0.05. Results: The study showed that there was no difference on the levels of interleukin level10 among mesenchymal stem cell conditioned medium goup and methyl prednisolone group (CM = 5,94 ± 2,49 pg/mL, mp = 5,86+1,73 pg/mL; p = 1) and the degree of pulmonary vasculitis (CM= 1,94 ± 0,25, MP=1,89+ 0,11 pg/ml; p = 0.667). Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice. Conclusion: Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice Bangladesh Journal of Medical Science Vol.20(2) 2021 p.426-430
AbstractList Background:Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive and anti-inflammatory properties. This study aims to compare the therapeutic effect of mesenchymal stem cell conditioned medium administration compared to methyl prednisolone on interleukin 10 levels and the degree of pulmonary vasculitis of lupus mice.Methods:The subjects were 24 female mice of Mus musculus Balb/C strain, which were categorized into 4 groups of 8 mice, i.e. the control group receiving 0.5 cc of 0.9% NaCl injection and placebo, the lupus group receiving 0.5 cc of pristane injection and placebo, and the treatment mesenchymal stem cell conditioned medium group receiving 0.5 cc pristane injection and mesenchymal stem cell conditioned medium 0,5 cc, and methylprednisolone group receiving 0,5 cc pristiane injection and methylprednisolone p.o 1,5 mg/kgbodyweight. After 24 days the mice were terminated and kidney and blood samples were taken. Statistical analysis was performed using ANOVA test followed by independent T-test. The p value was considered significant when the p < 0.05.Results:The study showed that there was no difference on the levels of interleukin level10 among mesenchymal stem cell conditioned medium goup and methyl prednisolone group (CM = 5,94 ± 2,49 pg/mL, mp = 5,86+1,73 pg/mL; p = 1) and the degree of pulmonary vasculitis (CM= 1,94 ± 0,25, MP=1,89+ 0,11 pg/ml; p = 0.667). Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice.Conclusion:Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice
Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive and anti-inflammatory properties. This study aims to compare the therapeutic effect of mesenchymal stem cell conditioned medium administration compared to methyl prednisolone on interleukin 10 levels and the degree of pulmonary vasculitis of lupus mice. Methods: The subjects were 24 female mice of Mus musculus Balb/C strain, which were categorized into 4 groups of 8 mice, i.e. the control group receiving 0.5 cc of 0.9% NaCl injection and placebo, the lupus group receiving 0.5 cc of pristane injection and placebo, and the treatment mesenchymal stem cell conditioned medium group receiving 0.5 cc pristane injection and mesenchymal stem cell conditioned medium 0,5 cc, and methylprednisolone group receiving 0,5 cc pristiane injection and methylprednisolone p.o 1,5 mg/kgbodyweight. After 24 days the mice were terminated and kidney and blood samples were taken. Statistical analysis was performed using ANOVA test followed by independent T-test. The p value was considered significant when the p < 0.05. Results: The study showed that there was no difference on the levels of interleukin level10 among mesenchymal stem cell conditioned medium goup and methyl prednisolone group (CM = 5,94 ± 2,49 pg/mL, mp = 5,86+1,73 pg/mL; p = 1) and the degree of pulmonary vasculitis (CM= 1,94 ± 0,25, MP=1,89+ 0,11 pg/ml; p = 0.667). Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice. Conclusion: Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice Bangladesh Journal of Medical Science Vol.20(2) 2021 p.426-430
Author Werdiningsih, Yulyani
Adnan, Zainal Arifin
Prabowo, Nurhasan Agung
Nurudhin, Arief
Prasetyo, Kukuh
Author_xml – sequence: 1
  givenname: Nurhasan Agung
  surname: Prabowo
  fullname: Prabowo, Nurhasan Agung
– sequence: 2
  givenname: Zainal Arifin
  surname: Adnan
  fullname: Adnan, Zainal Arifin
– sequence: 3
  givenname: Arief
  surname: Nurudhin
  fullname: Nurudhin, Arief
– sequence: 4
  givenname: Yulyani
  surname: Werdiningsih
  fullname: Werdiningsih, Yulyani
– sequence: 5
  givenname: Kukuh
  surname: Prasetyo
  fullname: Prasetyo, Kukuh
BookMark eNp1kU1rGzEQhkVxoK6Te4-CntfVh3elPRa3TQM2MeTjumilWVuuVnKl3YB_T_5otXFPhcxlBvG88w56P6GZDx4Q-kzJknNWf22PfVq-MGLZsqRlRT6gOSOiKgir61meGePFSjD6Ed2kdCS5KkLKWs7R6xYSeH0498rhhwF6vAbn8Dp4YwebXQzegrFjj1XCtyGYqW9hOJwd3kUw3qbgMoatx99BR1DJ-j3ewAu4hEOH7_wA0cH4OwOUYOUNfjxAZvcRYAJ2o-uDV_GMn1XSo8u2adq2GU9jtrIartFVp1yCm399gZ5-_nhc_yo297d362-bQnPKh6I2FWgoYcWpMKpmrexKkV8oFdRALbiUHUijSmJWol1J1bYlJwBci0opSvkCfbnsPcXwZ4Q0NMcwRp8tGyZZRaUUdZkpcqF0DClF6JpTtH2-v6GkmdJopjSatzSatzSypPpPou2gpu8dorLufeFf-jiU_w
CitedBy_id crossref_primary_10_1088_1755_1315_824_1_012058
crossref_primary_10_4028_p_7lJFTP
ContentType Journal Article
Copyright 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.3329/bjms.v20i2.51560
DatabaseName CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2076-0299
EndPage 430
ExternalDocumentID 10_3329_bjms_v20i2_51560
GroupedDBID 7RV
7X7
8FI
8FJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
BENPR
BKEYQ
BPHCQ
BVXVI
CCPQU
CITATION
DIK
EBD
EOJEC
ESX
FYUFA
GROUPED_DOAJ
GX1
HMCUK
KQ8
MK0
NAPCQ
OBODZ
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
TUS
UKHRP
3V.
7XB
8FK
AZQEC
DWQXO
K9.
M48
PKEHL
PPXIY
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c313t-9d6ece5e4317da92b8f57ece1171de97388fe8da50d47b48abb530ee3c76aa113
IEDL.DBID 7X7
ISSN 2223-4721
IngestDate Fri Jul 25 08:29:33 EDT 2025
Thu Apr 24 22:53:56 EDT 2025
Tue Jul 01 03:33:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language English
License http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c313t-9d6ece5e4317da92b8f57ece1171de97388fe8da50d47b48abb530ee3c76aa113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.proquest.com/docview/2826188795?pq-origsite=%requestingapplication%
PQID 2826188795
PQPubID 2040930
PageCount 5
ParticipantIDs proquest_journals_2826188795
crossref_primary_10_3329_bjms_v20i2_51560
crossref_citationtrail_10_3329_bjms_v20i2_51560
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-01
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Dhaka
PublicationPlace_xml – name: Dhaka
PublicationTitle Bangladesh journal of medical science (Ibn Sina Trust)
PublicationYear 2021
Publisher Ibn Sina Trust
Publisher_xml – name: Ibn Sina Trust
SSID ssj0000600598
ssib008506666
Score 2.1858687
Snippet Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has...
Background:Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has...
SourceID proquest
crossref
SourceType Aggregation Database
Enrichment Source
Index Database
StartPage 426
SubjectTerms Cytokines
Lupus
Phosphates
Stem cells
Title Mesenchymal Stem Cell Conditioned Medium as Good as Methyl Prednisolone in Decreasing Levels of Interleukin 10 and The Degree of Pulmonary Vasculitis in Lupus Mice
URI https://www.proquest.com/docview/2826188795
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: KQ8
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: DOA
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate (EBSCO)
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: ABDBF
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: DIK
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: GX1
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2076-0299
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000600598
  issn: 2223-4721
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtNAcAWthLhUPEWhRHvgwmEbr9eP9QlB6EOoqSKgKDdrH2MRcOw0jpH6PfwoMxuHqpdebMkee62d8bwfjL1zSWF85iqhiywRSBSR0AqMsFJpSFTmtSE_5PQyO79KvszT-eBw64a0yh1PDIzat4585GM0DTKpaTT2h9W1oKlRFF0dRmg8ZPsSVRWi6nx-K06pG9tOPd9yZqq1DEPqUCqKBK2fbeRSqbgY21_L7vhPHC3i45Tqi-9KqruMOkif0yfsYFAb-cctnp-yB9A8Y4-mQ2D8Ofs7pSoi9_NmiVDfNrDkE6hrPmkpIk3NiDwn4H7JTcfP2tbTeQqIpZrP1uCbBdIggvFFwz8HTZJ8CPyCUoo63lY8eA5r6H8jgIy4aTxHCkNYtNeBAGZ9jVtk1jf8R0hupV5J9LaLftXjUsiPXrCr05Pvk3MxzF8QTkm1EYXPwEEKpGN4U8RWV2mOV6TMpYciV1pXoL1JI5_kNtHG2lRFAMrlmTFSqpdsr8FPf8W402CL3PlIeaCMVgsgqSY4rlxBVughG-_2unRDc3KakVGXaKQQdkrCThmwUwbsHLL3_59YbRtz3AN7tENfOfyiXXlLUK_vv_2GPY4pkSWkah-xvc26h7eoiWzsKJDbiO1_OrmcfR0Fex6PZ3P5D_jJ4LA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxFMtFNgDHDi48Xr9WB8QQiklpXFViRblZta7Ywg4dohjUH4Pd34jM35Q9dJbT5bs8UP-Pu3svBl7afxY29DkjopD30FSuI6SoJ1MSAW-DK3S5IdMTsLJuf9xFsy22N-hFobSKoc1sV2obWXIRz5C0yAUikZjv13-dGhqFEVXhxEaHS2OYfMbTbb6zdEB4vvK8w7fn40nTj9VwDFSyLUT2xAMBECa0-rYy1QeRHhGiEhYiCOpVA7K6sC1fpT5SmdZIF0AaaJQayEkPvcGu-lL16de_dHsQn1T97fBHOg0AdV2tkPxUAs7PlpbXaRUSi8eZd8X9f4vz517-wHVM1_WjJcVQ6vtDu-xu_02lb_reHWfbUH5gN1K-kD8Q_Ynoaol822zQKlPa1jwMRQFH1cUAafmR5aTcLPguuYfqsrSMQFkRcFPV2DLOXIexfi85AftzpV8FnxKKUw1r3LeeioLaH6ggHC5Li1HRqPs1xUACZw2BUKiVxv-uU2mpd5M9LRps2zwVbj-PWLn14LMY7Zd4qfvMG4UZHFkrCstUAZtBiCoBtnLTUxW7y4bDf86NX0zdJrJUaRoFBE6KaGTtuikLTq77PX_O5ZdI5ArZPcG-NJ-SajTCwI_ufryC3Z7cpZM0-nRyfFTdsejJJo2TXyPba9XDTzDXdA6e95Sj7Mv1831f0yIG20
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+Stem+Cell+Conditioned+Medium+as+Good+as+Methyl+Prednisolone+in+Decreasing+Levels+of+Interleukin+10+and+The+Degree+of+Pulmonary+Vasculitis+in+Lupus+Mice&rft.jtitle=Bangladesh+journal+of+medical+science+%28Ibn+Sina+Trust%29&rft.au=Prabowo%2C+Nurhasan+Agung&rft.au=Adnan%2C+Zainal+Arifin&rft.au=Nurudhin%2C+Arief&rft.au=Werdiningsih%2C+Yulyani&rft.date=2021-02-01&rft.issn=2223-4721&rft.eissn=2076-0299&rft.volume=20&rft.issue=2&rft.spage=426&rft.epage=430&rft_id=info:doi/10.3329%2Fbjms.v20i2.51560&rft.externalDBID=n%2Fa&rft.externalDocID=10_3329_bjms_v20i2_51560
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2223-4721&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2223-4721&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2223-4721&client=summon